BA
NVIV

BlackRock Advisors’s InVivo Therapeutics Holdings Corp NVIV Stock Holding History

BlackRock Advisors’s Portfolio NVIV Stock Details NVIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$75K Hold
1
– – ﹤0.01% 3146
2016
Q3 		$114K Hold
1
– – ﹤0.01% 2968
2016
Q2 		$86K Hold
1
– – ﹤0.01% 3032
2016
Q1 		$115K Buy
+1
New +$107K ﹤0.01% 2854
2015
Q4 		– Sell
-1
Closed -$149K – 3137
2015
Q3 		$112K Hold
1
– – ﹤0.01% 3045
2015
Q2 		$217K Buy
+1
New +$264K ﹤0.01% 2755

Other funds holding NVIV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
WF
Welch & Forbes Boston, Massachusetts $7.73B AUM 14.94% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ICM
IMS Capital Management Portland, Oregon $217M AUM 18.69% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
GC
Guggenheim Capital Chicago, Illinois $12.9B AUM 27.3% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock Advisors's NVIV Position: Q4 2016 in Review

BlackRock Advisors held its InVivo Therapeutics Holdings Corp (NVIV) position steady in Q4 2016 at 1 share worth $75K. The position accounts for ﹤0.01% of the portfolio, ranked #3146.

BlackRock Advisors first reported a position in NVIV in Q2 2015 and has held it in 6 quarters since. The position peaked at $217K in Q2 2015. 51 funds tracked by Wall St. Rank hold NVIV as of Q4 2016.

  • BlackRock Advisors held 1 share of InVivo Therapeutics Holdings Corp worth $75K as of Q4 2016.
  • BlackRock Advisors left its InVivo Therapeutics Holdings Corp share count unchanged in Q4 2016.
  • InVivo Therapeutics Holdings Corp made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #3146 holding.
  • BlackRock Advisors first reported a position in InVivo Therapeutics Holdings Corp in Q2 2015 and has held it in 6 quarters since.
  • BlackRock Advisors's InVivo Therapeutics Holdings Corp position peaked at $217K in Q2 2015.
  • 51 funds tracked by Wall St. Rank held InVivo Therapeutics Holdings Corp as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.